Table 2.
Clinical characteristics of patients with follow-up
| Age | Gender | Eye | BCVAb (logMAR) | Concomitant eye disease | Extent of RRD* | Macula off/on | PVR | Procedure | Complication | Follow up time (months) | Final outcome | BCVAf (logMAR) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 95 | m | OS | 2.3 | glaucoma | 1 | off | no | SB, PPV, C2F6, laserpexy | no | 1.6 | RA | 0.7 |
| 2 | 96 | f | OD | 0.5 | amd | 1 | on | no | PPV,silicone oil, laserpexy | decalin leakage | 6 | RA | 0.7 |
| 3 | 94 | m | OS | 2.3 | no | 2 | off | yes | PPV, silicone oil, laserpexy | after 3 months silicon emulsification | 3 | RA | 0.3 |
| 4 | 91 | f | OS | 2.7 | high myopia | 4 | off | yes | PPV, C2F6 | no | 1 | RD | 2.3 |
| 5 | 93 | m | OS | 1.9 | no | 2 | off | no |
SB, 2nd procedure: PPV, silicone oil, laserpexy |
no | 9 | RA | 0.5 |
| 6 | 95 | m | OD | 2.3 | no | n.d | on | no | PPV, C2F6, cryopexy | no | 3 | RA | 0.4 |
| 7 | 93 | f | OD | 2.3 | glaucoma | 4 | off | no | PPV, silicone oil, laserpexy | no | 1 | RD | 2.3 |
| 8 | 95 | m | OS | 2.3 | hemianopia | 4 | off | yes | SB, PPV, silicone oil | no | 3 | RA | 2.3 |
| 9 | 93 | f | OS | 2.7 | no | 2 | off | no |
PPV, C2F6, laserpexy 2nd procedure: PPV, silicone oil, laserpexy |
subchoroidal hemorrhage | 37.6 | RD | 1.9 |
| 10 | 93 | f | OS | 2.7 | no | 4 | off | no | PPV, silicone oil, laserpexy | no | 2 | RD | 1.3 |
m male, f female, OD right eye, OS left eye, BCVAb baseline best corrected visual acuity, n.d. not detected, AMD Age related macular degeneration, PVR proliferative vitreoretinopathy, PPV pars plana vitrectomy, SB scleral buckling, RA reattachment, PD persistent detachment, RD redetachment, BCVA f final best corrected visual acuity
*The extent of RRD in involved quadrants